Compare INMB & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INMB | NTIC |
|---|---|---|
| Founded | 2015 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6M | 83.1M |
| IPO Year | 2018 | 1996 |
| Metric | INMB | NTIC |
|---|---|---|
| Price | $1.69 | $8.76 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.40 | N/A |
| AVG Volume (30 Days) | ★ 736.0K | 11.0K |
| Earning Date | 05-07-2026 | 04-09-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ 11.85 | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $50,000.00 | ★ $84,234,474.00 |
| Revenue This Year | N/A | $12.49 |
| Revenue Next Year | N/A | $7.64 |
| P/E Ratio | ★ N/A | $428.00 |
| Revenue Growth | ★ 257.14 | N/A |
| 52 Week Low | $1.09 | $7.14 |
| 52 Week High | $3.24 | $10.03 |
| Indicator | INMB | NTIC |
|---|---|---|
| Relative Strength Index (RSI) | 65.93 | 69.47 |
| Support Level | $1.37 | $8.55 |
| Resistance Level | $1.73 | $9.00 |
| Average True Range (ATR) | 0.13 | 0.19 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 88.57 | 85.21 |
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.